Bexar County, TX's Series 2010A And B Certificates Of Participation And 2010 GO Bonds Rated 'AA+'; Outlook Stable Jul 10

  • ID: 1922531
  • July 2010
  • Standard & Poors
1 of 3

DALLAS (Standard & Poor's) July 7, 2010--Standard & Poor's Ratings Services assigned its 'AA+' long-term rating, and stable outlook, to Bexar County, Texas' series 2010A and 2010B certificates of obligation (COPs), and series 2010 limited tax general obligation (GO) bonds. In addition Standard & Poor's affirmed its 'AA+' rating, with a stable outlook, on the county's GO debt outstanding and its 'A-1+' short-term rating on the county's commercial paper program. County officials plan to issue the series 2010B COPs as federally taxable Build America bonds (BABs), in which case the county will receive a subsidy from the U.S. treasury equal to 35% of the stated interest paid. The U.S. treasury subsidy for BABs, if issued, will be paid directly to...

Companies mentioned in this report are:
- Bexar Cnty

Action: Affirmed
Action: New Rating
Action: Outlook: Stable

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Bexar Cnty

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.